About
Basic Data Updated:
26 days agoHanugen Therapeutics Private Limited was founded with a vision to revolutionize the field of biopharmaceuticals through the development of cutting-edge oligonucleotide based therapeutics. The company's primary focus is on creating innovative treatments that can address a wide range of diseases and medical conditions. These therapeutics are designed to target specific genetic sequences and provide personalized treatment options for patients. HTPL has a diverse portfolio of clients, including prestigious organizations such as birac, KBITS, startup karnataka, and c-camp. These partnerships have allowed the company to access valuable resources and expertise, enabling them to accelerate their research and development efforts. As a result, HTPL has made significant strides in the development of novel therapeutics and has garnered recognition within the biopharmaceutical industry. The company's team of dedicated scientists and researchers work tirelessly to discover and develop new oligonucleotide based therapeutics. Their passion for innovation and commitment to improving patient outcomes drives them to push the boundaries of science and technology. With a strong focus on collaboration and a deep understanding of the complexities of genetic diseases, HTPL is poised to make a significant impact in the field of biopharmaceuticals.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U73200KA2017PTC100686 |
| Company No. | 100686 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 20 Feb 2017 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Financials of Hanugen Therapeutics Private Limited
Hanugen Therapeutics Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.32% decrease. The company also saw a substantial improvement in profitability, with a 22.9% increase in profit. The company's net worth Soared by an impressive increase of 43.45%.
Corporate Structure
Unlock access to Hanugen Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Hanugen Therapeutics Private Limited
Unlock and access historical data on people associated with Hanugen Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hanugen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hanugen Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Annual General Meeting
Hanugen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Hanugen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Director Appointment
Rav Deep Singh Anand was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 7 years 3 months .
20 Feb 2017Director Appointment
Arun Shastry was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 7 years 3 months .
20 Feb 2017Director Appointment
Manjulam was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 7 years 3 months .
20 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Hanugen Therapeutics Private Limited?
